Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 285Breast Neoplasms 283Lung Neoplasms 132Prostatic Neoplasms 123Colorectal Neoplasms 112Carcinoma, Non-Small-Cell Lung 107Pancreatic Neoplasms 69Carcinoma, Hepatocellular 58Stomach Neoplasms 53Ovarian Neoplasms 52Hematologic Neoplasms 51Multiple Myeloma 50Brain Neoplasms 50Urinary Bladder Neoplasms 49Leukemia, Myeloid, Acute 47Melanoma 46Esophageal Neoplasms 46Disease 42Head and Neck Neoplasms 41Colonic Neoplasms 39Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Liver Neoplasms 36Neoplasm Metastasis 35Lymphoma 33Leukemia, Lymphocytic, Chronic, B-Cell 31Endometrial Neoplasms 31Uterine Cervical Neoplasms 30Thyroid Neoplasms 30Recurrence 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphohistiocytosis, Hemophagocytic × 90 days × Clear all
NCT03827343 2026-06-05

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

National Institutes of Health Clinical Center (CC)

Active not recruiting
500 enrolled
Myeloid

Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡